Skip to content
IFPMA Twitter
IFPMA LinkedIn
IFPMA Youtube
IFPMA Slideshare
IFPMA Flickr
IFPMA RSS
Search for:
Primary Menu
Who We Are
IFPMA in Brief
Our Governance and Leadership
Our Membership
Full Members
Associations
Companies
Affiliate Members
Our Experts
Join Us
Topics
News Center
News Releases
Blog
Global Health Matters
Science Matters
Contributors
Statements
Latest News from Our Members
Resources
Publications
News Releases
Statements
Position Papers
Publications
External Studies
Infographics
Event Highlights
Multimedia
Interviews
Podcasts
Videos
Photos
Slides
IFPMA Interactive Platforms
IFPMA COVID-19 Hub
Global Health Progress
50 Years of Global Health Progress
Events
Upcoming IFPMA Events
Geneva Pharma Forums
Assemblies
Other IFPMA Events
IFPMA in External Events
IFPMA Press Briefings
Past IFPMA Events
Geneva Pharma Forums
Assemblies
Other IFPMA Events
IFPMA in External Events
IFPMA Press Briefings
Partners
BCR
Discovering medicines and Vaccines
Strengthening Regulatory Systems
Ethics and Business Integrity
Boosting Innovation and Access
Tackling Global health challenges
Economic footprint
IP
Pharma by numbers
Sustainable innovation
Value of innovation
spotlight
Value of innovation
African Medicines Agency
Biosimilars
Biotherapeutic medicines
Falsified medicines
Import testing
Pharma by numbers
Pharmacovigiliance
Quality, safety, and efficacy
Regulatory conferences
Regulatory system strengthening / Harmonization
Supply chain
The Africa Regulatory Network (ARN)
The ARN: Le réseau africain de réglementation pharmaceutique
spotlight
Pharmacovigiliance
IFPMA Code of Practice (2019)
Our Ethos
Code eLearning Tool
IFPMA Notes for Guidance
IFPMA Complaint Operating Procedure
How to File a Code Complaint
Complaint Submission Form
Cases
Business Ethics for APEC SMEs Initiative
Consensus Framework for Ethical Collaboration
spotlight
IFPMA Code of Practice (2019)
Access to medicines
Health technology assessment
IP
Pharma by numbers
Trade
spotlight
Access to medicines
Ageing
Antimicrobial resistance
Cancer
Child and maternal health
Diabetes
Do you mind? campaign
Ebola
Falsified medicines
Health partnerships
HIV/AIDS
Humanitarian and disaster relief aid
Influenza vaccine
Malaria
Mental and neurological disorders
Neglected tropical diseases
Non-communicable diseases
Novel Coronavirus (COVID-19)
Pandemic influenza preparedness
Pharma by numbers
Psoriasis
Rare diseases
Seasonal influenza
Supply chain
Sustainable development goals
Tuberculosis
Universal Health Coverage
Vaccines innovation
Vaccines protect communities
Vaccines sustainability
Value of immunization
Viral hepatitis
Workplace wellness
Zika Virus
spotlight
Universal Health Coverage
Home
>
Tag: global health security
Tag: global health security
IFPMA Policy Principles on COVID-19 Vaccines Initiative
Innovative vaccine industry strongly committed to rigorous regulatory standards for approval of COVID-19 vaccines
IFPMA Statement - Access to COVID-19 Tools Accelerator (ACT-Accelerator) Investment Case
IFPMA Statement at Gavi Alliance Global Vaccine Summit 2020 (Video)
Pharma pledges to continue 20 year partnership with Gavi, the Vaccine Alliance
Biopharmaceutical Industry Statement at Gavi, the Vaccine Alliance – Global Vaccine Summit 2020
IFPMA Statement on the “Solidarity Call to Action to realize equitable global access to COVID-19 health technologies through pooling of knowledge, intellectual property and data”
Global Biopharma CEO/Top Executives COVID-19 Media Briefing - 28 May 2020 (Video)
Pharma partners in efforts to give coronavirus vaccine for everyone
Pharma industry updates advice on engaging with healthcare professionals as countries emerge from COVID-19 lockdown
Ethical Considerations for Resuming In-Person Interactions with Healthcare Professionals Post COVID-19: A Guidance Document
Generation Gavi: Partnering to protect health through life-saving vaccines
Pharma and other innovative health groups tell World Health Assembly it stands united with governments and global health stakeholders worldwide to combat COVID-19
Joint Statement – Innovative Health Industries @ WHA73
COVID-19 Biopharmaceutical Industry – Regulatory Guiding Principles
IFPMA President David Ricks on Global Pledge Committing to Work Together to Beat COVID-19 (Video)
Pharma Joins Global Pledge Committing to Work Together to Beat COVID-19
Pharma Statement for The Coronavirus Global Response Pledging Marathon
Global Biopharma CEO/Top Executives Virtual Press Briefing - 30 April 2020 (Video)
Global Pharma update on unprecedented efforts to collaborate in speeding up the search for safe and effective COVID-19 therapies
Pharma industry body joins as founding partner a new global collaboration to accelerate the development, production and equitable access to new COVID-19 tools
IFPMA Statement on the launch of a new global collaboration to accelerate the development, production and equitable access to new COVID-19 tools
Innovative health industries united in welcoming United Nations General Assembly Resolution on “International Cooperation to ensure global access to medicines, vaccines and medical equipment to face COVID-19"
The value of the Ethos in the context of COVID-19
IFPMA remarks on intellectual property management and the global response to COVID-19
The biopharmaceutical industry commitments to tackle the coronavirus pandemic (Video playlist)
Pharma CEO/Top Executives Global Response to COVID-19 - Virtual Press Briefing - 19 March 2020 (Video)
Global Biopharmaceutical Industry Commitment to Address Coronavirus Public Health Crisis
Novel Coronavirus (COVID-19)
IFPMA and WHO Global Research and Innovation Forum
1
2
Next »
Other Tags
Access
Access to antiretrovirals
Access to Medicines
Access to vaccines
Africa
AMR
AMR Industry Alliance
Anti-Counterfeit
Antibiotics
antimicrobial resistance
antivirals
Assembly
Biosimilars
Biotherapeutic Medicines
Biotherapeutics
Cancer
Clinical Trials
Code of Practice
collaboration
Counterfeit Medicines
Counterfeits
COVID-19
Dementia
Developing World
Economic footprint
Efficacy
Epidemics
Ethics
Event Highlights
Fake Medicines
Fakes
Falsified Medicines
Fight the Fakes
Flu
Global Health
global health security
harmonization
Health Partnerships
HIV/AIDS
IFPMA
IFPMA Statement
Immunization
Incremental Innovation
Influenza
Influenza Vaccination
Infographic
Infographics
Innovation
Innovation ecosystem
Intellectual Property
IP
IVS
Malaria
MDGs
Medicines
Mental and Neurological Disorders
NCDs
Neglected Tropical Diseases
News Releases
Non-Communicable Diseases
Novel Coronavirus (COVID-19)
NTDs
pandemic
Pandemic Influenza
Pandemic preparedness
pandemics
Partnerships
Pharma
Pharmacovigilance
Position Paper
Prevention
Publications
Public Health
Quality
R&D
Regulatory
regulatory systems
Related Links
Research
Safety
SDGs
Seasonal Influenza
Statements
Supply chain
Sustainable Development Goals
Sustainable Innovation
trade
Transparency
Treatments
Tuberculosis
UHC
Universal Health Coverage
Vaccine
Vaccines
Value of Innovation
Videos
WHA
WHO
WIPO
Women’s Cancers
Cookie Policy
This website uses cookies to ensure you get the best experience on our website.
Learn More
Decline
Allow Cookies